RecruitingPhase 4

Assessing the Efficacy of Lemongrass and Lavender Aromatherapy in Reducing Dental Anxiety and Pain Associated With Local Anesthetic Injections in Pediatric Dental Patients

Egypt48 participantsStarted 2025-02-21

Plain-language summary

The goal of this clinical trial is to evaluate whether aromatherapy using lemongrass or lavender essential oils can reduce dental anxiety and pain perception in children aged 7-11 years undergoing local anesthetic administration in a pediatric dental setting. The main questions it aims to answer are: Does lemongrass or lavender aromatherapy reduce anxiety levels, as measured by salivary cortisol, in children receiving local anesthesia? Does aromatherapy influence pain perception and physiological stress (heart rate) during the procedure? Researchers will compare a lavender aromatherapy group, a lemongrass aromatherapy group, and a control group without aromatherapy to see if the essential oils have a calming effect that reduces anxiety and pain compared to no intervention. Participants will: Inhale either lavender, lemongrass, or no essential oil (control) for two minutes via nebulizer. Undergo local anesthesia administration for a dental procedure. Provide unstimulated and stimulated saliva samples before and after the procedure for cortisol analysis. Report their pain level using the Wong-Baker Faces Pain Rating Scale. Have their heart rate measured before and after the procedure using a finger-type pulse oximeter.

Who can participate

Age range

7 Years – 11 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * children aged 7-11 years * medically free * children category 3 or 4 according to Frankle behavior rating scale * patients who approve of signing informed consent and give child assent * children with at least one vital primary molar with deep carious lesion Exclusion Criteria: * children with a previous dental visit * children suffering from any upper or lower respiratory tract problems * children with any history of allergy children who currently use any medications

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

anxiety level

Timeframe: salivary cortisol will be assessed by taking saliva samples at baseline, and within 30 minutes of the procedure

Trial details

NCT IDNCT07113080

SponsorHiba Ahmed Eltayeb

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11

Contact for this trial

hiba AE suliman, master degree candidate

1119078420 hibaeltayeb@dent.asu.edu.eg

View on ClinicalTrials.gov More Dental Fear and Anxiety trials